Zero Gravity Solutions, Inc.’s Announces the Publication of an Important Research Paper in the International Journal of Biochemistry Research and Review

Rhea-AI Summary

Zero Gravity Solutions, Inc. (ZGSI) announced a published research paper by the International Journal of Biochemistry Research and Review showcasing its technology that activates plants' innate disease defenses. The study identifies new plant biomarkers in response to fungal attacks, confirming the technology's efficacy in enhancing plant resilience. ZGSI aims to expand its product line with proprietary priming elicitors, anticipating a significant shift towards sustainable agricultural solutions. The research strengthens the company's position in the agricultural biotechnology sector, furthering its commitment to innovative priming technologies.

Positive

• Research validates technology that activates plants' natural disease defenses.
• Identified new plant biomarkers under fungal attack, enhancing the understanding of plant resilience.
• Plans to broaden product suite with proprietary priming elicitors for increased yield and disease protection.
• Ongoing commercial success of BAM-FX product reinforces the effectiveness of the priming technology.

Negative

• None.

BOCA RATON, Fla.--(BUSINESS WIRE)-- Zero Gravity Solutions, Inc. (“ZGSI” or the “Company”) (Pink Sheets: ZGSI), an agricultural biotechnology company, announced that the International Journal of Biochemistry Research and Review has published a peer reviewed research paper outlining the mechanism by which the Company’s technology activates plants’ innate disease defenses. In this illustrative case study, the Company identified new plant biomarkers expressed when a plant is under fungal attack and demonstrated how our technology successfully triggers plants natural fungal defenses, a response known as priming. The findings validate the technology’s mode of action and pave the way for the Company to broaden its product suite with proprietary priming elicitors that enable plants to sustainably increase yield and protect against disease.

“Identifying the molecular mechanism of BAM priming and the specific biomarkers it causes to express is a scientific breakthrough for the Company. Our research validates our theory that a plant's natural defenses are triggered by the Company's priming technology”, stated Dr. Ravi Pottathil, Zero Gravity Solutions’ Chief Science Officer. “We believe the next generation of sustainable agricultural solutions will come from priming applications. We intend to introduce novel elicitor formulations as part of our priming technology platform in the near future based upon the biomarkers we have identified.”

The Company expects that use of priming technologies will be the next category of agricultural product innovation to achieve green and sustainable agriculture practices. The Company’s technology platform, which has been validated through numerous third-party trials both domestically and internationally, is at the forefront of an expected increasing use of priming agents as potent tools to mitigate plant disease.

"The findings of our recent research, combined with the ongoing commercial success of our BAM-FX product, reinforces our position that our priming technology is a leading edge innovation that will continue to contribute strongly to the tools that a grower has available to naturally boost the biological potential of their crops," said Timothy Peach, CEO/CFO of Zero Gravity Solutions, Inc.

The referenced published research paper is available at: https://journalijbcrr.com/index.php/IJBCRR

About Zero Gravity Solutions, Inc.

Zero Gravity Solutions, Inc. is an agricultural biotechnology public company with technology derived from and designed for Space with significant applications here on Earth. These technologies are focused on providing valuable solutions to challenges facing world agriculture. The commercialization activities are being executed through ZGSI’s two operating subsidiaries, BAM Agricultural Solutions, Inc. and Specialty Agricultural Solutions, Inc.

This press release may contain certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation, acceptance of the Company’s products, increased levels of competition for the Company, new products and technological changes, the Company’s dependence on third-party suppliers, and other risks detailed from time to time in the Company’s periodic reports filed with the Securities and Exchange Commission. Except as required by applicable law or regulation, Zero Gravity Solutions undertakes no obligation to update these forward-looking statements to reflect events or circumstances that occur after the date on which such statements were made.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220126005321/en/

Zero Gravity Solutions, Inc.

Julie Bloch, VP Communications

+1 561.416.0400

info@zerogsi.com

Source: Zero Gravity Solutions, Inc.

FAQ

What is the recent research published by Zero Gravity Solutions, Inc. (ZGSI)?

Zero Gravity Solutions, Inc. published research in the International Journal of Biochemistry Research and Review, demonstrating how its technology triggers plants' innate disease defenses.

How does ZGSI's technology enhance plant disease resistance?

ZGSI's technology activates plant defense mechanisms by identifying biomarkers that respond to fungal attacks, leading to improved disease resistance.

What are priming elicitors and how does ZGSI plan to use them?

Priming elicitors are proprietary formulations that ZGSI intends to introduce to boost plant yield and protect against diseases based on identified biomarkers.

What is the significance of the recent findings for ZGSI's future products?

The findings validate ZGSI's technology and allow the company to expand its product offerings in sustainable agriculture, contributing to innovative farming solutions.

How does the success of BAM-FX relate to ZGSI's technology?

The commercial success of BAM-FX strengthens ZGSI's position in the market, indicating that its priming technology is an effective tool for enhancing crop resilience.